These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32683035)

  • 1. A review of saponin intervention in metabolic syndrome suggests further study on intestinal microbiota.
    Luo Z; Xu W; Zhang Y; Di L; Shan J
    Pharmacol Res; 2020 Oct; 160():105088. PubMed ID: 32683035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akebia saponin D ameliorates metabolic syndrome (MetS) via remodeling gut microbiota and attenuating intestinal barrier injury.
    Yang S; Hu T; Liu H; Lv YL; Zhang W; Li H; Xuan L; Gong LL; Liu LH
    Biomed Pharmacother; 2021 Jun; 138():111441. PubMed ID: 33652261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic mechanisms of traditional Chinese medicine to improve metabolic diseases via the gut microbiota.
    Zhang HY; Tian JX; Lian FM; Li M; Liu WK; Zhen Z; Liao JQ; Tong XL
    Biomed Pharmacother; 2021 Jan; 133():110857. PubMed ID: 33197760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota-based translational biomarkers to prevent metabolic syndrome via nutritional modulation.
    Xiao S; Zhao L
    FEMS Microbiol Ecol; 2014 Feb; 87(2):303-14. PubMed ID: 24219358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of Lipoprotein Profile and Metabolic Endotoxemia by a Lifestyle Intervention That Modifies the Gut Microbiota in Subjects With Metabolic Syndrome.
    Guevara-Cruz M; Flores-López AG; Aguilar-López M; Sánchez-Tapia M; Medina-Vera I; Díaz D; Tovar AR; Torres N
    J Am Heart Assoc; 2019 Sep; 8(17):e012401. PubMed ID: 31451009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time.
    de Groot P; Scheithauer T; Bakker GJ; Prodan A; Levin E; Khan MT; Herrema H; Ackermans M; Serlie MJM; de Brauw M; Levels JHM; Sales A; Gerdes VE; Ståhlman M; Schimmel AWM; Dallinga-Thie G; Bergman JJ; Holleman F; Hoekstra JBL; Groen A; Bäckhed F; Nieuwdorp M
    Gut; 2020 Mar; 69(3):502-512. PubMed ID: 31147381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiome of a porcine model of metabolic syndrome and HF-pEF.
    O'Donovan AN; Herisson FM; Fouhy F; Ryan PM; Whelan D; Johnson CN; Cluzel G; Ross RP; Stanton C; Caplice NM
    Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H590-H603. PubMed ID: 32031871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Microbiota and obesity].
    Karney A
    Dev Period Med; 2017; 21(3):203-207. PubMed ID: 29077559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corni Fructus as a Natural Resource Can Treat Type 2 Diabetes by Regulating Gut Microbiota.
    Niu D; An S; Chen X; Bi H; Zhang Q; Wang T; Han B; Zhang H; Kang J
    Am J Chin Med; 2020; 48(6):1385-1407. PubMed ID: 32907359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marine polysaccharides attenuate metabolic syndrome by fermentation products and altering gut microbiota: An overview.
    Wang X; Wang X; Jiang H; Cai C; Li G; Hao J; Yu G
    Carbohydr Polym; 2018 Sep; 195():601-612. PubMed ID: 29805017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total saponins from Panax japonicus regulated the intestinal microbiota to alleviate lipid metabolism disorders in aging mice.
    Hu Y; Wang S; Wang R; Zhang Y; Yuan Q; Yuan C
    Arch Gerontol Geriatr; 2024 Oct; 125():105500. PubMed ID: 38851092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyphenol- and Caffeine-Rich Postfermented Pu-erh Tea Improves Diet-Induced Metabolic Syndrome by Remodeling Intestinal Homeostasis in Mice.
    Gao X; Xie Q; Kong P; Liu L; Sun S; Xiong B; Huang B; Yan L; Sheng J; Xiang H
    Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29061705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bletilla striata oligosaccharides improve metabolic syndrome through modulation of gut microbiota and intestinal metabolites in high fat diet-fed mice.
    Hu B; Ye C; Leung EL; Zhu L; Hu H; Zhang Z; Zheng J; Liu H
    Pharmacol Res; 2020 Sep; 159():104942. PubMed ID: 32504835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral hydroxysafflor yellow A reduces obesity in mice by modulating the gut microbiota and serum metabolism.
    Liu J; Yue S; Yang Z; Feng W; Meng X; Wang A; Peng C; Wang C; Yan D
    Pharmacol Res; 2018 Aug; 134():40-50. PubMed ID: 29787870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xiexin Tang ameliorates dyslipidemia in high-fat diet-induced obese rats via elevating gut microbiota-derived short chain fatty acids production and adjusting energy metabolism.
    Xiao S; Zhang Z; Chen M; Zou J; Jiang S; Qian D; Duan J
    J Ethnopharmacol; 2019 Sep; 241():112032. PubMed ID: 31220598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D signaling maintains intestinal innate immunity and gut microbiota: potential intervention for metabolic syndrome and NAFLD.
    Zeng Y; Luo M; Pan L; Chen Y; Guo S; Luo D; Zhu L; Liu Y; Pan L; Xu S; Zhang R; Zhang C; Wu P; Ge L; Noureddin M; Pandol SJ; Han YP
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G542-G553. PubMed ID: 31984787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eriobotrya japonica leaf triterpenoid acids ameliorate metabolic syndrome in C57BL/6J mice fed with high-fat diet.
    Li F; Li Y; Li Q; Shi X
    Biomed Pharmacother; 2020 Dec; 132():110866. PubMed ID: 33113426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.